Recent news on Cefoxitin

Orchid’s turnover rises to Rs 934cr during FY06-07  -  May 4, 2007
Moneycontrol.com,Ramp-up in volume market share in key cephalosporin products like Cefoxitin and Cefazolin injections helped power growth. Orchid is currently the sole

Orchid to foray into Canadian generic market  -  Apr 3, 2007
Hindu,These approvals correspond to two generic formulations -- Cefoxitin and Ceftriaxone -- which are covered under the exclusive marketing arrangement that the

3M pushes its MRSA test  -  Apr 11, 2007
Medical Laboratory World,3M has now launched the test Europe-wide using a cefoxitin formulation, which the firm says will be constantly updated to cover the emerging strains of MRSA

Orchid gets nod for Canada foray  -  Apr 3, 2007
Business Standard,According to a release issued by Orchid to the BSE today, the approvals are for two generic formulations - Cefoxitin and Ceftriaxone.

Canada okays two Orchid drug applications  -  Apr 3, 2007
Andhra Cafe,These ANDS (Abbreviated New Drug Submission) application approvals correspond to two generic formulations, Cefoxitin and Ceftriaxone.

CDC Issues New Treatment Recommendations for Gonorrhea  -  Apr 16, 2007
Medscape (subscription)...cephalosporin single-dose regimens (ceftizoxime, 500 mg IM; or cefoxitin, 2 g IM, administered with probenecid, 1 g orally; or cefotaxime, 500 mg IM).

CDC: Fluoroquinolones No Longer Recommended for Treatment of Gonorrhea  -  Apr 12, 2007
Food Consumer,Alternative parenteral single-dose regimens for urogenital and anorectal gonorrhea include ceftizoxime 500 mg, cefoxitin 2 g with probenecid 1 g orally,

Orchid enters Canadian market with two generic formulations  -  Apr 10, 2007
domain-B,...cefoxitin and ceftriaxone from the Canadian Therapeutic Product Directorate (TPD) Orchid has tied up with leading Canadian generics major,

Drug cos chase cats, dogs in US  -  Apr 3, 2007
Daily News & Analysis,...medicines market with the approval for its ANDA for generic formulations of cefoxitin and ceftriaxone, by the Canadian therapeutic products directorate.

B. Braun Launches DUPLEX(R) for Use with CeFOXItin; Company Now ...  Jun 26, 2006
B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the launch of CeFOXItin 1g and 2g for injection in the ... -Genetic Engineering News

B. Braun Launches DUPLEX for Use with CeFOXItin; Company Now ...  Jun 26, 2006
WIRE)--Jun 26, 2006 - B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the launch of CeFOXItin 1g and 2g ... -PharmaLive.com



Supply Hotline Established to Assist Customers Affected By Supply ...  May 2, 2006
...leader in innovative healthcare products and services, announced today the recent US Food and Drug Administration (FDA) approval of CeFOXItin for injection in ... - Genetic Engineering News

Orchid launches generic drugs in US  Apr 28, 2006
The products launchced in US markets are Cephalexin, Cefazolin, Ceftriaxone, Cefprozil and Cefoxitin, the company Managing director K Raghavendra Rao said in a ... - Economic Times



Indices decline on profit booking  Feb 14, 2006
...equipment for ships. Orchid Chemicals has received the final US FDA approval for cefoxitin in injectible form. IVRCL Infrastructure ... - domain-B,

Orchid Chem receives USFDA approval for Cefoxitin  Jan 27, 2006
...major Orchid Chemicals & Pharmaceuticals Ltd has received USFDA approval for its Abbreviated New Drug Application (ANDA) for the antibiotic, Cefoxitin, 1 gm ... - Hindustan Times

Orchid Chemicals gets US FDA nod for Cefoxitin injection  Jan 26, 2006
Ltd has announced that it has received the formal approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Cefoxitin for injection, 1 gm ... - Hindu Business Line

Orchid gets USFDA nod for Cefoxitin  Jan 27, 2006
...& Pharmaceuticals Ltd today said it has received the formal approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Cefoxitin for injection ... - NewKerala.com

Orchid Chemicals receives USFDA approval for Cefoxitin injection ...  Jan 26, 2006
Q, N,C,F)* & Pharmaceuticals Ltd has received the formal approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Cefoxitin for injection, 1 ... - Myiris.com

Wrap up: Sensex vaults 185 points  Jan 27, 2006
Orchid Chemicals gained 5.3 per cent (Rs 262.35) on the news that it has received the formal approval from the USFDA for its ANDA for Cefoxitin for injection ... - Myiris.com

Sensex above 9800 as steel, banking, engineering and auto stocks ...  Jan 27, 2006
Orchid Chemicals informed the exchanges that it has received the final US FDA approval for the drug cefoxitin in injectible form. ... - domain-B

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional